For many years I thought my friends with medical marijuana cards were just looking for a legal loophole to get high and goof around—and for the most part I was right. But I had never considered it before. Besides, I was perfectly happy with my stash of relatively low-dose recreational cannabis, which I started taking sometime in 2017 when my lower back pain became untenable. Then I injured my back (again) during a particularly intense month of contact combat training with fighters twice my size. It had been years since it last happened and I was in a panic.
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska’s research group at Turku Bioscience observed that SORLA functionally contributes to the most reported therapy-resistant mechanism by which the cell-surface receptor HER3 counteracts HER2
SALT LAKE CITY — A southern Utah lawmaker wants to prohibit doctors from offering any gender reassignment treatment to minors.
“These are young kids … these are minors that — and I do have a lot of empathy for maybe kids feeling like they’re a male in a female body or vice versa — but these puberty blockers that they take can have permanent effect on their bodies,” said bill sponsor Rep. Rex Shipp, R-Cedar City.
Under HB92, physicians and surgeons would be restricted from performing gender reassignment treatment on those under 18, including internal surgeries and facial feminization
The MarketWatch News Department was not involved in the creation of this content.
Jan 29, 2021 (Heraldkeepers) —
A New Market Study, titled “Medical Waste Treatment Service Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
This report provides in depth study of “Medical Waste Treatment Service Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Medical Waste Treatment Service Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product
Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Malignant mesothelioma is intractable cancer, and no phase III trial has yet shown an improvement in overall survival following the standard first-line chemotherapy doublet comprising pemetrexed and cisplatin or carboplatin since it was licensed in 2004.
Professor Dean Fennell, chair of Thoracic Medical Oncology at the University of Leicester in collaboration with Professor Gareth Griffiths and his team at the Southampton Clinical Trials Unit, University of Southampton, UK,
Patients with substance use disorders (SUDs) being treated for serious medical conditions are more likely to leave the hospital against medical advice (AMA) than those without addiction. A special type of contract with healthcare providers might enable patients to consent in advance to life-saving medical care—even if they later refuse treatment, according to a commentary in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM).
The Substance Use Advance Directive (SUAD) “has the potential to greatly improve the current state of treatment for life-threatening comorbid conditions in SUD